Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - entrectinib - capsule - 100 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - entrectinib 100 mg/1 cap - 100 mg/1 cap

Philippines - English - FDA (Food And Drug Administration)

f. hoffman-la roche ag; importer: roche (philippines), inc.; distributor: roche (philippines), inc. - entrectinib - capsule - 100 mg

Philippines - English - FDA (Food And Drug Administration)

f. hoffman-la roche ag; importer: roche (philippines), inc.; distributor: roche (philippines), inc. - entrectinib nib - capsule - 200 mg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

chugai pharmaceutical co., ltd. - entrectinib - light yellow capsule, major axis: approx. 18.0 mm, minor axis: approx. 6.1 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

chugai pharmaceutical co., ltd. - entrectinib - bright yellow-red capsule, major axis: approx. 21.8 mm, minor axis: approx. 7.3 mm

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - itraconazole 10 mg/ml - oral solution - 10 mg/ml - active: itraconazole 10 mg/ml excipient: caramel cherry flavour 654536 cherry flavour 654595 hydrochloric acid hydroxypropyl-beta-cyclodextrin propylene glycol purified water saccharin sodium sodium hydroxide sorbitol - sporanox oral solution is indicated for the: · treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. · prophylaxis of fungal infections in neutropenic patients.

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - itraconazole - oral solution - 10 milligram(s)/millilitre - triazole derivatives; itraconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - itraconazole - capsule, hard - 100 milligram(s) - triazole derivatives; itraconazole